NovaBridge Biosciences

1. Ragistomig Ph1 topline2026Ragistomig Ph1 topline, 2026, major
2. Uliledlimab Ph1 readout2H 2026Uliledlimab Ph1 readout, 2H 2026, material
3. Givastomig Ph3 startearly 4Q 2026Givastomig Ph3 start, early 4Q 2026, notable
4. Givastomig Ph1 readoutOct 25, 2026Givastomig Ph1 readout, Oct 25, 2026, major
5. Givastomig Ph2 readout2027Givastomig Ph2 readout, 2027, notable
6. VIS-101 Ph3 start2027VIS-101 Ph3 start, 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.